Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO Breast 2020 | EMBRACA & OlympiAD: targeting DNA repair

Jennifer Litton • 7 May 2020
ESMO Breast 2020
Breast Cancer Olaparib Talazoparib
EMBRACA OlympiAD

Jennifer Litton, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives us an overview of of targeting DNA repair in breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Jennifer Litton

2:56
Managing breast cancer during pregnancy
Jennifer Litton • 14 May 2020
2:34
Genetic testing: changing the face of cancer care
Jennifer Litton • 13 May 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals